$1.06
+0.09 (+9.27%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,230.2% upside
Low Target
$17.28
Average Target
$24.70
High Target
$43.03
Current Price
$1.06
Current
$1.06
$1.06
Target
$24.70
$24.70
$17.28
$24.70 avg
$43.03
Scenario Analysis
Bear Case
$17.28
1,530.2%
Low target
Base Case
$24.70
+2,230.2%
Avg target
Bull Case
$43.03
+3,959.4%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$5.48
-80.7% from high
52-Week Low
$0.69
+53.4% from low
Target vs 52W High
$24.70
+350.7% vs high
Next Earnings Report
Apr 13, 2026 · After Market Close
11d
until earnings
Earnings in 11 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +19.8% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.0% |
| GILD | Strong Buy | 38 | 79% | $362.68 | +158.5% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -2.0% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.1% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -13.0% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -29.7% |